Crossmark

Reduced hsa-miR-124-3p levels are associated with the poor survival of patients with hepatocellular carcinoma

Crossref DOI link: https://doi.org/10.1007/s11033-018-4431-1

Published Online: 2018-10-19

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Long, Hui-Deng

Ma, Yu-Shui

Yang, Hui-Qiong

Xue, Shao-Bo

Liu, Ji-Bin

Yu, Fei

Lv, Zhong-Wei

Li, Ji-Yu

Xie, Ru-Ting

Chang, Zheng-Yan

Lu, Gai-Xia

Xie, Wen-Ting

Fu, Da

Pang, Li-Juan
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81560053)

National Natural Science Foundation of China (81772932)

National Natural Science Foundation of China (81201535)

National Natural Science Foundation of China (81302065)

National Natural Science Foundation of China (81472202)

National Natural Science Foundation of China (81301993)
License Information

Text and Data Mining valid from 2018-10-19
More Information

Article History

Received: 7 September 2018

Accepted: 9 October 2018

First Online: 19 October 2018

Compliance with ethical standards

:

: No potential conflicts of interest were disclosed.